Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Breast Cancer (Tokyo, Japan)|January 7, 2017
Complete remission in metastatic breast cancer: expecting the unexpected-results of a cross-sectional studyGiulia Galli, Anna Tessari, Luca Porcu, et al.
The British Journal of Surgery|March 5, 2025
Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trialRoberto Agresti, Marco Sandri, Giuseppe Capri, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 30, 2019
Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomesGiorgio Bogani, Maria Grazia Tibiletti, Maria Teresa Ricci, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2021
Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessmentAntonino Ditto, Loris De Cecco, Biagio Paolini, et al.
Journal of Minimally Invasive Gynecology|May 9, 2017
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective ExperienceGiorgio Bogani, Elena Tagliabue, Mauro Signorelli, et al.
Frontiers in Endocrinology|October 23, 2023
Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumorsEmanuela Minna, Andrea Devecchi, Federico Pistore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2023
Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal TreatmentRoberta Sanfilippo, Marta Sbaraglia, Chiara Fabbroni, et al.
Breast (Edinburgh, Scotland)|June 27, 2017
Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breastMassimiliano Gennaro, Maria Carmen De Santis, Luigi Mariani, et al.
International Journal of Surgical Pathology|December 12, 2013
Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive casesGiuseppe Pelosi, Eva Regina Haspinger, Manuela Bimbatti, et al.
Cancers|January 13, 2019
Constitutive <i>BRCA1</i> Promoter Hypermethylation Can Be a Predisposing Event in Isolated Early-Onset Breast CancerJacopo Azzollini, Chiara Pesenti, Sara Pizzamiglio, et al.
Pageof 9